chr14-52268385-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000953.3(PTGDR):c.571G>A(p.Glu191Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000953.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTGDR | NM_000953.3 | c.571G>A | p.Glu191Lys | missense_variant | 1/2 | ENST00000306051.3 | NP_000944.1 | |
PTGDR | NM_001281469.2 | c.571G>A | p.Glu191Lys | missense_variant | 1/3 | NP_001268398.1 | ||
PTGDR | XM_005267891.5 | c.571G>A | p.Glu191Lys | missense_variant | 1/3 | XP_005267948.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTGDR | ENST00000306051.3 | c.571G>A | p.Glu191Lys | missense_variant | 1/2 | 1 | NM_000953.3 | ENSP00000303424.2 | ||
PTGDR | ENST00000553372.1 | c.571G>A | p.Glu191Lys | missense_variant | 1/3 | 3 | ENSP00000452408.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250134Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135346
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460084Hom.: 0 Cov.: 31 AF XY: 0.00000826 AC XY: 6AN XY: 726406
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.571G>A (p.E191K) alteration is located in exon 1 (coding exon 1) of the PTGDR gene. This alteration results from a G to A substitution at nucleotide position 571, causing the glutamic acid (E) at amino acid position 191 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at